# US 8,278,074 B2 · L-glutamic acid-producing microorganism and a method for producing L-glutamic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,074 B2
- Document ID: US8278074B2
- Status: Granted
- Kind: B2
- Application number: 13/047,260
- Filed: 2011-03-14
- Published: 2011-07-14
- Granted: 2012-10-02
- Earliest claimed: 2004-12-28
- Assignees: Ajinomoto Co., Inc.
- Inventors: Jun Nakamura; Seiko Hirano; Hisao Ito
- Web page: https://patentgrep.com/patent/US8278074B2

## CPC

- C12P 13/14: Glutamic acid; Glutamine
- C07K 14/34: from Corynebacterium (G)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A coryneform bacterium that is modified by using a yggB gene so that L-glutamic acid-producing ability is enhanced as compared to a non-modified strains is cultured in a medium to cause accumulation of L-glutamic acid in the medium or bacterial cells, and L-glutamic acid is collected from the medium or cells.

## Claims

### Claim 1

A method for producing a coryneform bacterium
comprising a mutant-type yggB gene, said method comprising:
a) introducing a random mutation into a wild-type yggB gene in vitro, resulting in a mutant-type yggB gene,
b) modifying a coryneform bacterium by transforming said coryneform bacterium with the mutant-type yggB gene;
c) inoculating a said coryneform bacterium of step b) into a medium containing not less than 30 μg/1 of biotin, and
d) selecting coryneform bacteria that show increased accumulation of L-glutamic acid-in the medium as compared to a non-modified coryneform bacterium.

### Claim 2

A method for producing a coryneform bacterium comprising a mutant-type yggB gene, said method comprising:
a) modifying a coryneform bacterium by randomly introducing a transposable element into the chromosome of said coryneform bacterium,
b) inoculating said coryneform bacterium of step (a) into a medium containing not less than 30 μg/1 of biotin,
c) screening for coryneform bacteria that show increased accumulation of L-glutamic acid in the medium as compared to a non-modified coryneform bacterium, and
d) selecting coryneform bacteria comprising a mutant-type yggB by determining the nucleotide sequence of the yggB gene on the chromosome of the bacteria.

### Claim 3

A method for producing a coryneform bacterium comprising a mutant type yggB gene, said method comprising:
a) inoculating a coryneform bacterium into a medium containing L-glutamic acid analogs,
b) screening for coryneform bacteria which grows on the medium containing L-glutamic acid analogs, and
c) selecting coryneform bacteria comprising a mutant-type yggB gene by determining the nucleotide sequence of the yggB gene.

### Claim 4

A method for producing a coryneform bacterium comprising a mutant-type yggB gene, said method comprising:
a) modifying a coryneform bacterium by inoculating said coryneform bacterium which is deficient in a gene encoding α-ketoglutarate dehydrogenase into a medium containing not less than 30 μg/l of biotin, and
b) selecting coryneform bacteria that show increased accumulation of L-glutamic acid in the medium as compared to a non-modified coryneform bacterium;
c) selecting coryneform bacteria comprising a mutant-type yggB gene by determining the nucleotide sequence of the mutant-type yggB gene in coryneform bacteria selected in step (b).

### Claim 5 (depends on 1)

The method according to claim 1, said method further comprising a step of determining the nucleotide sequence of the yggB gene in coryneform bacteria selected in step (d).
